miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.
about
Genomic landscape of megakaryopoiesis and platelet function defectsMiR-155 Knockout in Fibroblasts Improves Cardiac Remodeling by Targeting Tumor Protein p53-Inducible Nuclear Protein 1MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study.Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis.A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells.Literature-based condition-specific miRNA-mRNA target predictionNormal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutationsMicroRNA-363 and GATA-1 are regulated by HIF-1α in K562 cells under hypoxia.Emerging drugs for diffuse large B-cell lymphoma.Ofatumumab for the treatment of chronic lymphocytic leukemia.Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.Treatment of chronic lymphocytic leukemia with monoclonal antibodies, where are we heading?Pacritinib: a new agent for the management of myelofibrosis?MicroRNAs in Myeloid Hematological Malignancies.Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.Ofatumumab for treating chronic lymphocytic leukemia: a safety profile.Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients.A myeloid tumor suppressor role for NOL3Identification of the ectoenzyme CD38 as a marker of committed preadipocytes.HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.An overview of investigational Histone deacetylase inhibitors (HDACis) for the treatment of non-Hodgkin's lymphoma.Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM WorkshopA review of the venous thrombotic issues associated with multiple myeloma.Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary MyelofibrosisImproving Antibody-Based Cancer Therapeutics Through Glycan Engineering.Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.A Tiny RNA that Packs a Big Punch: The Critical Role of a Viral miR-155 Ortholog in Lymphomagenesis in Marek's Disease.MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF.Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia.Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cellsIdentification of potential therapeutic target genes and miRNAs for primary myelofibrosis with microarray analysis.miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6.Integrative testis transcriptome analysis reveals differentially expressed miRNAs and their mRNA targets during early puberty in Atlantic salmon.CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles.Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.
P2860
Q26770869-B27663B6-C2A7-49D2-867F-159765985D2EQ28505621-B6857E66-DF25-4037-83A5-F9DFEF2CA044Q30277191-333121A1-23B9-49D2-A809-EED405DD38EBQ31019526-9CBAD25A-1CA1-4A1D-B1C2-A35B96F970BCQ31110460-E24DF588-789E-4B93-977D-19CCDF89166CQ33431806-BF159FA6-193D-465F-A20C-77628909B74AQ35808066-94E4BB4E-3C51-4254-A2FC-D28B623A1441Q35976594-E52800A6-243B-4D1E-8651-92FFFFBBB7B7Q36330181-FE73B2BB-9088-490F-A469-01691BF27261Q37046277-B097D2A1-B894-4ECB-B69B-1D3EB69A94C5Q37190977-11E37F0A-DA30-4483-9ACC-0C8828D912C4Q38344404-346C96FC-6DB0-48D8-ABB3-86BBD4C80100Q38424862-45D7A619-0720-489F-B6AE-9042FA00B179Q38567540-C11D3B6A-AC91-4ADC-9D0B-4A4F04CC1D69Q38573785-71C105C6-48D0-4710-B2FC-6A951714C02AQ38590232-639B4A63-893D-42CC-B0A0-1A1A2E71A0F0Q38599595-D84A3619-1001-4162-90FD-DCB8AE3C1B07Q38608986-147EB33A-4EAA-4EA4-B5F5-D715C02EB9E5Q38632940-9CD7E031-1678-481F-81A3-B661F66405C3Q38660742-D22F3CDC-5A35-4110-AE30-B4DDE9F181C8Q38715127-77C79247-CCAF-4481-BB9C-6642CE0829E0Q38726949-27F4FAD0-5E2F-4240-B73F-9C5FAA9B61AAQ38753227-17307D0C-515B-4EE1-AD69-144AD8AB35C8Q38765451-73ADBA81-9883-4DB0-903E-B91B73CB8A19Q38821875-21381130-E604-4490-8064-B4D86F34389BQ38845946-0A294CDF-9D71-491B-A02C-BE98587AB992Q38850667-FB355703-5551-44DC-9274-315EE4CF4858Q39015118-72E23F0C-EA7A-453E-A62C-3D6687CBC0BBQ39279968-C65056F8-A5F3-4CC8-9720-DA889A4A9917Q39327365-1BAA398B-2148-49C9-AEBC-2D46AFA9C970Q39427070-617987C0-F771-414B-99EC-8DEA2380C8B9Q39742982-FE3302DC-745C-4057-BBC4-66510A4C0F94Q41219902-01731193-51B0-4F6D-BA3C-D92E4C297B91Q41225286-9C19C372-26BF-4209-8E80-F4C230445E0FQ41472526-0F63819B-DE56-4CF0-8282-0A5E47C09075Q41665045-8E66EACA-AC61-46A5-9699-D31CD82F5BF8Q42089573-2340263F-2204-4589-905C-BC34B3A332B9Q42672072-8320605A-B762-4B1D-9A06-F6104D515FA7Q47347862-7379BC7B-703B-438F-A063-044A9C93E3CEQ47347914-44E681E8-F3A0-4029-A28A-CDE352FF0827
P2860
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
miRNA-mRNA integrative analysi ...... in abnormal megakaryopoiesis.
@en
miRNA-mRNA integrative analysi ...... in abnormal megakaryopoiesis.
@nl
type
label
miRNA-mRNA integrative analysi ...... in abnormal megakaryopoiesis.
@en
miRNA-mRNA integrative analysi ...... in abnormal megakaryopoiesis.
@nl
prefLabel
miRNA-mRNA integrative analysi ...... in abnormal megakaryopoiesis.
@en
miRNA-mRNA integrative analysi ...... in abnormal megakaryopoiesis.
@nl
P2093
P2860
P50
P1433
P1476
miRNA-mRNA integrative analysi ...... in abnormal megakaryopoiesis.
@en
P2093
Alessandro M Vannucchi
Alessandro Rambaldi
Andrea Bisognin
Associazione Italiana per la R ...... eloproliferative Investigators
Carmela Mannarelli
Costanza Bogani
Giorgia Sacchi
Giovanni Barosi
Mario Cazzola
Ruggiero Norfo
P2860
P304
P356
10.1182/BLOOD-2013-12-544197
P407
P50
P577
2014-08-05T00:00:00Z